VCM
AZN icon

Voleon Capital Management’s AstraZeneca AZN Stock Holding History

Voleon Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8M Buy
+125,385
New +$23.6M 0.43% 48
2026
Q1 		– Sell
-7,863
Closed -$1.45M – 799
2025
Q4 		$1.45M Buy
7,863
+4,394
+127% +$771K 0.03% 384
2025
Q3 		$532K Buy
+3,469
New +$525K 0.01% 566

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Voleon Capital Management's AZN Position: Q2 2026 in Review

Voleon Capital Management opened a new position in AstraZeneca (AZN) in Q2 2026: 125,385 shares worth $23.8M. The stake represents 0.43% of the portfolio and ranks #48 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in AZN as recently as Q4 2025.

Voleon Capital Management first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Voleon Capital Management held 125,385 shares of AstraZeneca worth $23.8M as of Q2 2026.
  • AstraZeneca was a new Voleon Capital Management position in Q2 2026.
  • AstraZeneca made up 0.43% of Voleon Capital Management's portfolio in Q2 2026, its #48 holding.
  • Voleon Capital Management first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.